Wednesday, September 3, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Consumer & Luxury

Macy’s Faces Critical Test with Upcoming Q2 Earnings Report

Felix Baarz by Felix Baarz
August 31, 2025
in Consumer & Luxury, Earnings, Turnaround
0
Macy's Stock
0
SHARES
15
VIEWS
Share on FacebookShare on Twitter

All eyes are on Macy’s as the struggling retail giant prepares to release its second-quarter financial results next week. The report arrives amid lowered expectations and dimmed forecasts, presenting a crucial moment for the company’s ongoing turnaround efforts.

The company is scheduled to announce its quarterly performance before markets open on Wednesday, September 3rd. Market experts anticipate revenue to fall within a range of $4.69 to $4.74 billion, with projected earnings of $0.19 per share. Macy’s continues to navigate a complex landscape marked by trade tariffs, cautious consumer spending, and intense retail sector competition.

In a move that signaled persistent headwinds, Macy’s management had already tempered its full-year 2025 guidance. The company revised its annual profit forecast downward to a range of $1.60 to $2.00 per share. However, its revenue outlook for the year remained steady, maintained at $21.0 to $21.4 billion.

Should investors sell immediately? Or is it worth buying Macy's?

Turnaround Strategy Under Scrutiny

The core of the company’s future hinges on its ambitious “Bold New Chapter” restructuring plan. This radical strategy involves closing 150 underperforming locations by 2026 while simultaneously modernizing and expanding 125 of its most promising stores. Early indicators from the first quarter showed some positive momentum: credit card revenue surged by an impressive 31.6% to $154 million, and the gross margin held firm at 39.2%.

Despite these glimmers of progress, market sentiment remains largely skeptical. The average analyst price target for Macy’s stock sits around $13.22, only marginally above its current trading level. Sentiment among researchers is cautious; out of twelve analysts covering the stock, nine currently advise holding, while just one recommends buying.

For income-focused investors, the recent dividend payment of $0.1824 per share provides a modest silver lining. The central question, however, is whether this can offset the deeper structural issues the retailer faces. The upcoming quarterly figures will be pivotal in determining if Macy’s can finally initiate the long-awaited recovery or if it will confirm the market’s most pessimistic fears.

Ad

Macy's Stock: Buy or Sell?! New Macy's Analysis from September 3 delivers the answer:

The latest Macy's figures speak for themselves: Urgent action needed for Macy's investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 3.

Macy's: Buy or sell? Read more here...

Tags: Macy's
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Ryohin Keikaku Stock
Analysis

Ryohin Keikaku Shares Face Market Pressure Despite Robust Sales Performance

September 3, 2025
Corbus Stock
Analysis

Corbus Shares Advance as Pipeline Progress Takes Center Stage

September 3, 2025
Liveramp Stock
Analysis

LiveRamp Stock: A Tale of Conflicting Analyst Views

September 3, 2025
Next Post
Costco Stock

Costco's Bold Membership Strategy: Rewarding Premium Customers

Marin Software Stock

Marin Software's Nasdaq Exit Culminates in Chapter 11 Restructuring and Shareholder Wipeout

Lufax Holding Stock

Leadership Shifts and Dividend Impact at Lufax Amid Trading Halt

Recommended

Pharmaceutical Markets and money

Mixed Results from PL9643 MELODY1 Phase 3 Clinical Trial for Dry Eye Disease

2 years ago
Finance_ Investing in stocks

Monroe Capital Corporation Q4 Earnings Report Review

1 year ago

BullFrog AI Holdings Inc Secures Australian Patent for Groundbreaking Prodrugs Derived from Mebendazole

2 years ago
Technology Artificial intelligence Market Capitalization

Super Micro Computers Stock Soars on Growing Demand for AI Servers

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba AMD AMZN Apple BA Broadcom C Coca-Cola Coinbase COST CRWD DIS Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSFT NIO Nvidia Opendoor Oracle Palantir PayPal PLTR Red Cat Robinhood Rocket Lab USA Salesforce SMCI Strategy Take-Two Tesla Tilray TSLA Unitedhealth Wolfspeed
No Result
View All Result

Highlights

Viking Therapeutics Stock: A Study in Market Ambivalence

Activist Investor Pushes for Major Consolidation in US Food Distribution Sector

Regional Lender Main Bancshares Delivers Stunning Quarterly Surge

Healthcare Services Stock Soars Amid Data Breach Controversy

Blue Owl Capital Navigates Debt Deadline Amid Insider Selling

Tesla’s Global Performance: Regional Challenges and Emerging Opportunities

Trending

Ryohin Keikaku Stock
Analysis

Ryohin Keikaku Shares Face Market Pressure Despite Robust Sales Performance

by Felix Baarz
September 3, 2025
0

Ryohin Keikaku Co., the operator of the MUJI retail brand, finds itself in a curious market position....

Corbus Stock

Corbus Shares Advance as Pipeline Progress Takes Center Stage

September 3, 2025
Liveramp Stock

LiveRamp Stock: A Tale of Conflicting Analyst Views

September 3, 2025
Viking Therapeutics Stock

Viking Therapeutics Stock: A Study in Market Ambivalence

September 3, 2025
US Foods Stock

Activist Investor Pushes for Major Consolidation in US Food Distribution Sector

September 3, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Ryohin Keikaku Shares Face Market Pressure Despite Robust Sales Performance September 3, 2025
  • Corbus Shares Advance as Pipeline Progress Takes Center Stage September 3, 2025
  • LiveRamp Stock: A Tale of Conflicting Analyst Views September 3, 2025

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com